Literature DB >> 411417

Disodium phosphonoacetate in cream base as a possible topical treatment for skin lesions of herpes simplex virus in cebus monkeys.

A E Palmer, W T London, J L Sever.   

Abstract

Disodium phosphonoacetate (PAA) in a cream-ointment base was applied to herpesvirus skin lesions on the genitalia of cebus monkeys. The lesions had been produced by the intradermal injection of herpes simplex virus type 2. Concentrations of 0.2, 2, and 5% PAA were used. Liberal application of PAA at concentrations of 2 and 5% proved extremely irritating and produced extensive, severe lesions over the treated area. The 2% PAA, when applied carefully to the lesion area, proved less irritating, but did not reduce healing time when compared with the placebo-treated animals. The 0.2% PAA caused slight reduction in lesion size and duration, but these differences were not statistically significant when compared with placebo-treated animals.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411417      PMCID: PMC429955          DOI: 10.1128/AAC.12.4.510

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Inhibition of herpes simplex virus replication by phosphonoacetic acid.

Authors:  L R Overby; E E Robishaw; J B Schleicher; A Rueter; N L Shipkowitz; J C Mao
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

2.  Latent Herpesvirus hominis from trigeminal and sacral dorsal root ganglia of Cebus monkeys.

Authors:  W C Reeves; R F DiGiacomo; E R Alexander; C K Lee
Journal:  Proc Soc Exp Biol Med       Date:  1976-11

3.  A nonhuman primate model for the study of the cervical oncogenic potential of herpes simplex virus type 2.

Authors:  W T London; A J Nahmias; Z M Naib; D A Fuccillo; J H Ellenberg; J L Sever
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

4.  Genital herpesvirus hominis type 2 infection: an experimental model in cebus monkeys.

Authors:  A J Nahmias; W T London; L W Catalano; D A Fuccillo; J L Sever; C Graham
Journal:  Science       Date:  1971-01-22       Impact factor: 47.728

5.  Genital herpesvirus hominis Type 2 infection of monkeys.

Authors:  W T London; L W Catalano; A J Nahmias; D A Fuccillo; J L Sever
Journal:  Obstet Gynecol       Date:  1971-04       Impact factor: 7.661

6.  Suppression of herpes simplex virus infection by phosphonoacetic acid.

Authors:  N L Shipkowitz; R R Bower; R N Appell; C W Nordeen; L R Overby; W R Roderick; J B Schleicher; A M Von Esch
Journal:  Appl Microbiol       Date:  1973-09
  6 in total
  2 in total

1.  Treatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetate.

Authors:  E R Kern; L A Glasgow; J C Overall; J M Reno; J A Boezi
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

2.  Effect of trisodium phosphonoformate in genital infection of female guinea pigs with herpes simplex virus type 2.

Authors:  S Alenius; H Nordlinder
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.